euroscreen.com euroscreen.com

EUROSCREEN.COM

Euroscreen S.A. - Home

GPCR customized screening and other services for biotech and pharma companies around the world. Discovery and development of innovative small molecules as preclinical candidates targeting proprietary G Protein-Coupled Receptors (GPCR) for unmet medical needs. Located in Belgium, Europe.

http://www.euroscreen.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR EUROSCREEN.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.2 out of 5 with 11 reviews
5 star
1
4 star
4
3 star
4
2 star
0
1 star
2

Hey there! Start your review of euroscreen.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT EUROSCREEN.COM

WIN SA

Buki Nuredini

3 rue d●●●●●●●d'Andoy

Wi●●de , 5100

BE

32.8●●●●1706
32.8●●●●1736
dn●●●●●●●●@staff.win.be

View this contact

WIN SA

Buki Nuredini

3 rue d●●●●●●●d'Andoy

Wi●●de , 5100

BE

32.8●●●●1706
32.8●●●●1736
dn●●●●●●●●@staff.win.be

View this contact

WIN SA

Buki Nuredini

3 rue d●●●●●●●d'Andoy

Wi●●de , 5100

BE

32.8●●●●1706
32.8●●●●1736
dn●●●●●●●●@staff.win.be

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2004 January 21
UPDATED
2014 January 16
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 21

    YEARS

  • 9

    MONTHS

  • 17

    DAYS

NAME SERVERS

1
ns1.win.be
2
ns2.win.be

REGISTRAR

GANDI SAS

GANDI SAS

WHOIS : whois.gandi.net

REFERRED : http://www.gandi.net

CONTENT

SCORE

6.2

PAGE TITLE
Euroscreen S.A. - Home | euroscreen.com Reviews
<META>
DESCRIPTION
GPCR customized screening and other services for biotech and pharma companies around the world. Discovery and development of innovative small molecules as preclinical candidates targeting proprietary G Protein-Coupled Receptors (GPCR) for unmet medical needs. Located in Belgium, Europe.
<META>
KEYWORDS
1 skip to content
2 euroscreen s a
3 latest news
4 news
5 euroscreen fast
6 main menu
7 about euroscreen
8 discovery programs
9 business opportunities
10 contact euroscreen
CONTENT
Page content here
KEYWORDS ON
PAGE
skip to content,euroscreen s a,latest news,news,euroscreen fast,main menu,about euroscreen,discovery programs,business opportunities,contact euroscreen,career
SERVER
Apache/2.4.10 (Debian)
POWERED BY
PHP/5.6.33-0+deb8u1
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

Euroscreen S.A. - Home | euroscreen.com Reviews

https://euroscreen.com

GPCR customized screening and other services for biotech and pharma companies around the world. Discovery and development of innovative small molecules as preclinical candidates targeting proprietary G Protein-Coupled Receptors (GPCR) for unmet medical needs. Located in Belgium, Europe.

INTERNAL PAGES

euroscreen.com euroscreen.com
1

Euroscreen S.A. - Home

http://www.euroscreen.com/index.php

News and Press Releases. Business Opportunities and Licensing Inquiries. News and Press Releases. EUROSCREEN opens US-IND for ESN364 on three Phase. July 19th, 2016 – Euroscreen announced today that it has opened an Investigational Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to conduct pivotal efficacy and safety . News and Press Releases. Euroscreen SA strengthens its Management Team. News and Press Releases. News and Press Releases. News and Press Releases. Euroscreen starts...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

LINKS TO THIS WEBSITE

euroscreen.be euroscreen.be

Euroscreen S.A. - Home

http://www.euroscreen.be/index.php

News and Press Releases. Business Opportunities and Licensing Inquiries. News and Press Releases. EUROSCREEN opens US-IND for ESN364 on three Phase. July 19th, 2016 – Euroscreen announced today that it has opened an Investigational Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to conduct pivotal efficacy and safety . News and Press Releases. Euroscreen SA strengthens its Management Team. News and Press Releases. News and Press Releases. News and Press Releases. Euroscreen starts...

fundplus.be fundplus.be

Your project - fundplus

http://fundplus.be/your-project

If you have an innovative project that meets the criteria of our fund and you are looking for smart money, Fund. Could be your partner and shareholder. We will contact you within 15 days after submitting your project. In case of a positive evaluation you will be invited to give a company presentation. A due diligence will follow after a positive appraisal.

fundplus.be fundplus.be

News - fundplus

http://fundplus.be/press

Fund in the news. Octimet Oncology NV secures over EUR 11 million to develop it highly selective MET kinase inhibitors. Le francophile de la semaine: Chris Buyse. Belgian Fund raises 125 for biotech. Promethera Biosciences raises eur 10 million in a series c-extension financing to advance its broad product pipeline in liver diseases. Désiré Collen. Le scientifique qui fait fructifier les pépites. Fund prêt à investir 125 milions dans les biotechs belges. Le nouveau project du fondateur de ThromboGenics.

fundplus.be fundplus.be

Team - fundplus

http://fundplus.be/team

Jan Van den Bossche. Diane holds a bachelor degree in informatics. She joined Life Sciences Research Partners in 2007 as administrative assistant, where she still is in charge of the Administration, Human Resources and Bookkeeping. Diane joined Fund.

fundplus.be fundplus.be

About - fundplus

http://fundplus.be/about

In May 2015 the private foundation (“Private Stichting”) Désiré Collen and the non-profit organisation Life Sciences Research Partners founded Fund. The Fund has the legal form of a Belgian Naamloze Vennootschap/Société Anonyme (NV/SA) and has its registered offices in Groot Begijnhof of Leuven, a World Heritage Site. Will invest in innovative life sciences companies primarily active in therapeutics, without excluding however companies developing diagnostics and medical devices. As of today Fund.

fundplus.be fundplus.be

Board - fundplus

http://fundplus.be/board

Chairman of the board. François Fontaine joined the Board of Directors of Fund in December 2016. He has a law degree from ULB (Université Libre de Bruxelles) and a degree in fiscal sciences from the Brussels Management School (ICHEC). He is Fund Manager at SFPI-FPMI (the Federal Holding and Investment Company), one of the main investors of Fund .

fundplus.be fundplus.be

Portfolio companies - fundplus

http://fundplus.be/portfolio-companys

ETheRNA was established in January 2013 as a spin-off company of the ‘Vrije Universiteit Brussel’ (VUB), following the development of the TriMix technology by the VUB Laboratory for Molecular and Cellular Therapy, headed by Prof. Kris Thielemans (and co-founders Carlo Heirman and Sonja van Meirvenne) in tandem with Prof Bart Neyns from the Brussels University Hospital ‘UZ Brussel’. Established in 2013, Novadip BioSciences is a biomedical spin-off company from the University of Louvain (UCL, Belgium) and ...

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL LINKS TO THIS WEBSITE

11

OTHER SITES

euroscreed.co.uk euroscreed.co.uk

Welcome to European Screeding Ltd

Welcome to European Screeding Limited. Specialising in all aspects of floor Screeding to the construction industry. A 75mm Traditional Sand Cement Screed with a Thermal Insulation board was installed. Despite the very challenging logistics. The Snowdon Summit Visitors Centre was completed on schedule. Mclaren is just one of the Prestigious brands we have had the privilege of working with through our Shopfitting customers. We formally introduce you to European Screeding Ltd and express our keen interest i...

euroscreed.com euroscreed.com

euroscreed.com

euroscreen-discovery.com euroscreen-discovery.com

Euroscreen S.A. - Home

Skip to main navigation. Skip to 1st column. Skip to 2nd column. Skip to 2nd column. There are no Items to display. Euroscreen starts in parallel two Phase 2 clinical trials with ESN364 in UF and PCOS patients. Euroscreen receives 3.86 million Grant for GPCR Neurodegenerative Diseases Drug Development. Euroscreen Announces Positive Completion of Phase I Trial of ESN364. News and Press Releases. You are here :. Web Creation - Site-Creation.be.

euroscreen.ba-no.de euroscreen.ba-no.de

GLOBALSCREEN.ORG

euroscreen.be euroscreen.be

Euroscreen S.A. - Home

Skip to main navigation. Skip to 1st column. Skip to 2nd column. Skip to 2nd column. There are no Items to display. Euroscreen starts in parallel two Phase 2 clinical trials with ESN364 in UF and PCOS patients. Euroscreen receives 3.86 million Grant for GPCR Neurodegenerative Diseases Drug Development. Euroscreen Announces Positive Completion of Phase I Trial of ESN364. News and Press Releases. You are here :. Web Creation - Site-Creation.be.

euroscreen.com euroscreen.com

Euroscreen S.A. - Home

Skip to main navigation. Skip to 1st column. Skip to 2nd column. Skip to 2nd column. There are no Items to display. Euroscreen starts in parallel two Phase 2 clinical trials with ESN364 in UF and PCOS patients. Euroscreen receives 3.86 million Grant for GPCR Neurodegenerative Diseases Drug Development. Euroscreen Announces Positive Completion of Phase I Trial of ESN364. News and Press Releases. You are here :. Web Creation - Site-Creation.be.

euroscreen.com.au euroscreen.com.au

Euroscreen

Retractable screens for doors. Retractable screens for windows. Retractable insect screens protect you from flying pests like mosquitoes, however unlike fixed screens, they can be rolled up out of the way and out of view when not needed. Our retractable screens are suitable for most openings and windows, such as double hung and sliding type windows, as well as most types of doors. Suitable for interior and exterior installation. Available in many colours. Can be fitted to existing windows.

euroscreen.net euroscreen.net

Price Request - BuyDomains

Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.

euroscreen.org euroscreen.org

Price Request - BuyDomains

Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.

euroscreen.org.uk euroscreen.org.uk

Euroscreen

RT @Ystadskommun: Putting an accurate, quantitative value on screen tourism Engaging. posted on Twitter. Bream me up: William Shatner to captain Star Trek sea cruises from. posted on Twitter. Four days left to get Early Bird tickets for Mixed Reality in. posted on Twitter. RT @meta guide cz: Prague sees “Lost in Thailand effect” as Chinese tourism grows. posted on Twitter. RT @UxueIm: A lovely day visiting Highclere Castle with @MPilar Garcia @DowntonAbbey @EuroScreen2. posted on Twitter.

euroscreen.ru euroscreen.ru

euroscreen.ru - This website is for sale! - euroscreen Resources and Information.

This domain may be for sale - этот домен возможно продается. This domain may be for sale - этот домен возможно продается. This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.